MedPath

KOOTENAI HEALTH

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

1 Phases

Phase 4:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)β€’ Click on a phase to view related trials

Phase 4
2 (100.0%)

Hydroxychloroquine in SARS-CoV-2 (COVID-19) Pneumonia Trial

Phase 4
Withdrawn
Conditions
SARS-CoV-2 Pneumonia
COVID-19
Interventions
First Posted Date
2020-05-11
Last Posted Date
2021-02-05
Lead Sponsor
Kootenai Health
Registration Number
NCT04382625
Locations
πŸ‡ΊπŸ‡Έ

Kootenai Health, Coeur d'Alene, Idaho, United States

A Clinical Trial of Two Periarticular Multimodal Drug Injections in Total Hip and Knee Arthroplasty

First Posted Date
2015-09-07
Last Posted Date
2019-10-18
Lead Sponsor
Kootenai Health
Target Recruit Count
239
Registration Number
NCT02543801

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.